Brazil Inhalable Biologics Market Size & Outlook, 2025-2030
Related Markets
Brazil inhalable biologics market highlights
- The Brazil inhalable biologics market generated a revenue of USD 40.4 million in 2024 and is expected to reach USD 105.7 million by 2030.
- The Brazil market is expected to grow at a CAGR of 17.4% from 2025 to 2030.
- In terms of segment, peptides and proteins was the largest revenue generating type in 2024.
- RNAi-based Therapeutics is the most lucrative type segment registering the fastest growth during the forecast period.
Inhalable biologics market data book summary
| Market revenue in 2024 | USD 40.4 million |
| Market revenue in 2030 | USD 105.7 million |
| Growth rate | 17.4% (CAGR from 2025 to 2030) |
| Largest segment | Peptides and proteins |
| Fastest growing segment | RNAi-based Therapeutics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Peptides and Proteins, Vaccines, Monoclonal Antibodies, RNAi-based Therapeutics |
| Key market players worldwide | Kamada, MannKind, Ab Initio, Ocugen, CanSino Biologics Inc Class H, AstraZeneca PLC |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.1% of the global inhalable biologics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil inhalable biologics market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 48.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inhalable Biologics Market Scope
Inhalable Biologics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ocugen | View profile | 51-100 | Malvern, Pennsylvania, United States, North America | http://ocugen.com |
| Ab Initio | View profile | 501-1000 | Lexington, Massachusetts, United States, North America | http://www.abinitio.com |
| MannKind | View profile | 501-1000 | Valencia, California, United States, North America | http://mannkindcorp.com |
| Kamada | View profile | 101-250 | Ness Ziona, HaMerkaz, Israel, Asia | http://kamada.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| CanSino Biologics Inc Class H | View profile | 1494 | 185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, China, People's Republic of, | https://www.cansinotech.com |
Brazil inhalable biologics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhalable biologics market will help companies and investors design strategic landscapes.
Peptides and proteins was the largest segment with a revenue share of 34.9% in 2024. Horizon Databook has segmented the Brazil inhalable biologics market based on peptides and proteins, vaccines, monoclonal antibodies, rnai-based therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil's market growth is fueled by a high prevalence of respiratory conditions and a proactive approach by the government to improve healthcare outcomes.
Investments in local production of biopharmaceuticals and the expansion of healthcare infrastructure are enhancing the accessibility of inhaled biologic therapies.
Collaborations with international companies are also contributing to the availability of innovative treatments.
Reasons to subscribe to Brazil inhalable biologics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil inhalable biologics market databook
-
Our clientele includes a mix of inhalable biologics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil inhalable biologics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil inhalable biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil inhalable biologics market size, by application, 2018-2030 (US$M)
Brazil Inhalable Biologics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
